Hubei Goto Biopharm Co.,Ltd. (SHE:300966)
China
· Delayed Price · Currency is CNY 15.42
-0.24 (-1.53%)
Apr 25, 2025, 10:45 AM CST
Hubei Goto Biopharm Revenue
In the year 2024, Hubei Goto Biopharm had annual revenue of 536.60M CNY, down -5.26%. Hubei Goto Biopharm had revenue of 171.21M in the quarter ending December 31, 2024, a decrease of -5.60%.
Revenue
536.60M
Revenue Growth
-5.26%
P/S Ratio
3.35
Revenue / Employee
850.39K
Employees
631
Market Cap
1.80B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Jiangsu Hengrui Medicine | 27.98B |
| Shenzhen Mindray Bio-Medical Electronics | 37.11B |
| WuXi AppTec | 37.92B |
| Zhangzhou Pientzehuang Pharmaceutical., | 10.91B |
| Aier Eye Hospital Group | 20.62B |
| Shanghai United Imaging Healthcare | 10.30B |
| Sichuan Biokin Pharmaceutical | 5.82B |
| Yunnan Baiyao Group Co.,Ltd | 40.03B |